NextPharma sells logistics business to Cencora

NextPharma sells logistics arm to Cencora as part of plan to position NextPharma as Europe’s leading pure-play CDMO2nd December 2025

2nd December 2025 – NextPharma, a leading European pharmaceutical contract development and manufacturing organisation (“CDMO”), is pleased to announce that it has completed, as planned, the sale of its healthcare logistics services business, NextPharma Logistics GmbH, to Cencora, Inc., a global pharmaceutical solutions organisation. The divestment forms part of NextPharma’s strategic focus on strengthening its position as a leading European CDMO, dedicated to delivering the highest quality products and services to its customers. About NextPharma NextPharma is a leading European pharmaceutical contract development and manufacturing organisation (“CDMO”) with a current footprint spanning ten sites, five in Germany, two in France and one in each of Finland, Norway and Scotland. NextPharma supplies products globally, with all of its ten sites FDA-approved. With expertise in solids, semi solids and non-sterile and sterile liquids, the company provides services from pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms including tablets, chewable tablets, capsules, granules, powders, pellets, gels, creams, liquid-filled capsules, softgels, sprays and syrups. Additionally, it provides a wide range of packaging solutions including blow-fill-seal, blisters, bottles, sachets, stick packs and tubes. NextPharma’s expertise and centres of excellence enable it to provide a unique service offering in certain very specific specialised areas such as hormonal solids and semi-solids, cephalosporins, penicillins, modified release products, lipid-based formulations (including hormonal and high potent products), as well as paediatric medicinal products. For more information, please visit www.nextpharma.com.